logo
Plus   Neg
Share
Email

AstraZeneca: FDA Approves Self-administration For Fasenra In Fasenra Pen

AstraZeneca (AZN.L,AZN) said the US FDA has approved the self-administration of Fasenra in the Fasenra Pen, a pre-filled, single-use auto-injector. The approval is based on data from the Phase III GRECO trial and the Phase I AMES trial.

The company said Fasenra is now the only respiratory biologic that offers the choice of administration at home or in a doctor's office.

Fasenra is currently approved as an add-on maintenance treatment for severe eosinophilic asthma in the US, EU, Japan and other countries.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Uber Technologies Inc. (UBER) said Monday that it laid off about 350 employees across several different teams, as part of its final phase of layoffs of the process it began earlier this year. Porsche unveiled a cheaper version of its Taycan all-electric sports car, Taycan 4S. This is the third version of the sports saloon after Taycan Turbo S and Taycan Turbo launched in September. According to Porsche, Taycan 4S is now the new entry-level model in the Taycan series. The new model is available is two versions based on battery sizes. Howard University and Amazon Studios have jointly launched Howard Entertainment. The program is meant to give African-American students and other marginalized populations such as Latinx and Native American students an opportunity to train and study alongside executives in the entertainment industry. The program will begin in January 2020.
Follow RTT
>